Patient -
derived xenograft models of non-small cell lung cancer and their potential utility in personalized medicine.
«The ongoing line of work with this drug is an excellent example of the bench getting even closer to the bedside — our lab work with the drug in patient -
derived xenograft models of disease makes possible the clinical trials taking place at the University of Colorado Hospital next door,» Jimeno says.
Not exact matches
«Our data confirmed that, while the rate of growth of triple - negative breast cancer was not affected by CDK 4/6 inhibitors, this class of drugs was able to significantly inhibit the spread of triple - negative breast cancer to distant organs when tested in multiple different triple - negative breast cancer
models, including patient -
derived xenografts.»
EZH2 inhibition delayed tumor onset in KDM6A - null cells and caused regression of KDM6A - null bladder tumors in both patient -
derived and cell line
xenograft models.
In his current position at The Jackson Laboratory, he has overall responsibility for the ongoing operational development of the PDX resource, which generates, banks, and distributes patient -
derived xenograft (PDX) mouse
models of human cancers.
The researchers used an in vivo
model of PARP inhibitor resistance in patient -
derived tumor
xenografts (PDXs).
NCI's efforts to develop new laboratory
models of human cancer includes vastly increasing the number of human cancer cell lines (grown as two - dimensional and three - dimensional cultures) and patient -
derived tumor
xenografts.
Finally, I have a category of «other cancers» with exomes published in 2011; these include pancreastic cysts and cell lines, gastric cancer tumors, and prostate cancer samples
derived through mouse
xenograft models.
GLN - 1001 is currently in preclinical development, where it has been shown to dramatically prolong survival in patient
derived xenograft animal
models of glioblastoma.
They now show that engineering hESC - and iPSC -
derived NK cells with a specific HIV CD4ΞΆ chimeric receptor enhances the suppression of HIV replication in vitro and study these cells in a mouse
xenograft model [6].
The main research activity (located in central Paris and vicinity at Orsay) regroups to date 16 technology platforms and services offering state β of β the - art expertise and equipment from small molecule chemistry to omcs, super-resolution microscopy, sophisticated radiation sources and various animal
models, including
xenografts directly
derived from patients, in order to promote the best environment and support for research activities.
Liu JF, Palakurthi S, Zeng Q, Zhou S, Ivanova E, Huang W, Zervantonakis IK, Selfors LM, Shen Y, Pritchard CC, Zheng M, Adleff V, Papp E, Piao H, Novak M, Fotheringham S, Wulf G, English J, Kirschmeier PT, Velculescu VE, Paweletz CP, Mills GB, Livingston DM, Brugge JS, Matulonis UA, Drapkin R.: Establishment of patient -
derived tumor
xenograft models of epithelial ovarian cancer for pre-clinical evaluation of novel therapeutics.
The approach is to use clinically relevant tumor
models such as patient -
derived xenografts (PDXs), as well as humanized and immunocompetent transgenic tumor - bearing mice to design rational combinations of novel and emerging cancer therapies, including tumor - targeting and immune - stimulating therapies, to ultimately improve treatment outcomes for cancer patients.
These platforms include genetically engineered mouse (GEM)
models, fallopian tube -
derived cell lines, and patient -
derived tumor
xenografts.
Over 170 carefully curated, well - characterized patient -
derived xenograft tumor
models are available for use in your facility, or use Horizon's comprehensive preclinical in vivo efficacy service.